IBB - iShare Nasdaq Biotechnology ETF

[giofranchi]

I have sold some NKE and SBUX to open a new position in IBB.

It has fallen more than 30% from its 52 Week High and it has tested more than once a level that is 10% below the current price. Furthermore, some large cap biotech cos offer good value at these prices.

The sector as a whole I think will keep growing handsomely for the foreseeable future.

NKE and SBUX were already relatively small positions (I like both cos, but I think there is a meaningful multiple contraction risk). Now of course NKE, SBUX, and IBB are even smaller. But I would gladly buy much more of the three should prices come down.

 

Cheers,

 

Gio